Skip to main content
. 2020 Feb 27;19(4):3031–3041. doi: 10.3892/etm.2020.8564

Figure 6.

Figure 6

Safety endpoints of NSAIDs in ankylosing spondylitis. ORs among NSAIDs and placebo for (A) AEs and (B) gastrointestinal AEs. An OR of <1.0 indicates a benefit from therapy. AE, adverse event; NSAIDs, non-steroidal anti-inflammatory drugs; OR, odds ratio.